These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25347227)

  • 1. Single ketamine infusion and neurocognitive performance in bipolar depression.
    Permoda-Osip A; Kisielewski J; Bartkowska-Sniatkowska A; Rybakowski JK
    Pharmacopsychiatry; 2015 Mar; 48(2):78-9. PubMed ID: 25347227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?
    Rybakowski JK; Permoda-Osip A; Skibinska M; Adamski R; Bartkowska-Sniatkowska A
    Hum Psychopharmacol; 2013 Jan; 28(1):87-90. PubMed ID: 23124710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors connected with efficacy of single ketamine infusion in bipolar depression].
    Permoda-Osip A; Skibińska M; Bartkowska-Sniatkowska A; Kliwicki S; Chłopocka-Woźniak M; Rybakowski JK
    Psychiatr Pol; 2014; 48(1):35-47. PubMed ID: 24946433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression.
    Shiroma PR; Albott CS; Johns B; Thuras P; Wels J; Lim KO
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1805-13. PubMed ID: 24963561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
    Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression.
    Permoda-Osip A; Dorszewska J; Bartkowska-Sniatkowska A; Chlopocka-Wozniak M; Rybakowski JK
    Pharmacopsychiatry; 2013 Sep; 46(6):227-8. PubMed ID: 23846402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive and behavioural performance of healthy volunteers receiving an increasing analgesic-range infusion of ketamine.
    Hayley A; Green M; Downey L; Keane M; Kostakis P; Shehabi Y
    Psychopharmacology (Berl); 2018 Apr; 235(4):1273-1282. PubMed ID: 29476241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Affect Disord; 2019 Mar; 246():241-247. PubMed ID: 30590286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
    Young AH; Gallagher P; Watson S; Del-Estal D; Owen BM; Ferrier IN
    Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ketamine Versus Midazolam on Neurocognition at 24 Hours in Depressed Patients With Suicidal Ideation.
    Keilp JG; Madden SP; Marver JE; Frawley A; Burke AK; Herzallah MM; Gluck M; Mann JJ; Grunebaum MF
    J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34727422
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine for Bipolar Depression: A Systematic Review.
    Bahji A; Zarate CA; Vazquez GH
    Int J Neuropsychopharmacol; 2021 Jul; 24(7):535-541. PubMed ID: 33929489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.
    Lara DR; Bisol LW; Munari LR
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2111-7. PubMed ID: 23683309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and its associations with the path of illness in affective disorders: a comparison between patients with bipolar and unipolar depression in remission.
    Daniel BD; Montali A; Gerra ML; Innamorati M; Girardi P; Pompili M; Amore M
    J Psychiatr Pract; 2013 Jul; 19(4):275-87. PubMed ID: 23852102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine safety and tolerability in clinical trials for treatment-resistant depression.
    Wan LB; Levitch CF; Perez AM; Brallier JW; Iosifescu DV; Chang LC; Foulkes A; Mathew SJ; Charney DS; Murrough JW
    J Clin Psychiatry; 2015 Mar; 76(3):247-52. PubMed ID: 25271445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term relationships between neurocognitive performance and general function in bipolar disorder.
    Baune BT; Li X; Beblo T
    J Clin Exp Neuropsychol; 2013; 35(7):759-74. PubMed ID: 23944232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention and psychomotor functioning in bipolar depression.
    Burdick KE; Gunawardane N; Goldberg JF; Halperin JM; Garno JL; Malhotra AK
    Psychiatry Res; 2009 Apr; 166(2-3):192-200. PubMed ID: 19272656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression.
    Lai R; Katalinic N; Glue P; Somogyi AA; Mitchell PB; Leyden J; Harper S; Loo CK
    World J Biol Psychiatry; 2014 Sep; 15(7):579-84. PubMed ID: 24910102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.